Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.46 |
| ▸ | ALPI | P09923 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | XIAP | P98170 | 1/20 | 0.46 |
| ▸ | TPH1 | P17752 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tyrosine SCHEMBL3443100 | 0.96 | SLC7A5 (0.58) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL28846971 | 0.95 | SLC7A5 (0.57) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL9551454 | 0.93 | SLC7A5 (0.55) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL29176063 | 0.92 | SLC7A5 (0.53) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL1443654 | 0.92 | SLC7A5 (0.75) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL1443661 | 0.92 | SLC7A5 (0.75) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL27584006 | 0.91 | SLC7A5 (0.65) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL16820324 | 0.89 | SLC7A5 (0.71) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL3909629 | 0.89 | SLC7A5 (0.50) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL3909625 | 0.89 | SLC7A5 (0.50) | SLC7A5PTGS1ALPIPKMXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228573-A9 | METHOD FOR PRODUCING FUSION PROTEIN OF SERUM ALBUMIN AND GROWTH HORMONE | JCR PHARMACEUTICALS CO., LTD. (JP) | 2024-07-11 | — | — | US | disclosed |
| EP-4374913-A2 | NOVEL HUMAN SERUM ALBUMIN MUTANT | JCR Pharmaceuticals Co., Ltd. (JP) | 2024-05-29 | — | — | EP | disclosed |
| US-20240132566-A1 | METHOD FOR PRODUCING FUSION PROTEIN OF SERUM ALBUMIN AND GROWTH HORMONE | JCR PHARMACEUTICALS CO., LTD. (JP) | 2024-04-25 | — | — | US | disclosed |
| EP-3845644-B1 | NOVEL HUMAN SERUM ALBUMIN MUTANT | JAPAN CHEM RES (JP) | 2024-04-24 | — | — | EP | disclosed |
| CN-114591445-B | Novel human serum albumin mutant | JCR制药股份有限公司 | 2024-04-23 | — | — | CN | disclosed |
| CN-114728043-B | Aqueous pharmaceutical composition containing fusion protein of serum albumin and growth hormone | JCR制药股份有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-11634474-B2 | Human serum albumin mutant | JCR PHARMACEUTICALS CO., LTD. (JP) | 2023-04-25 | — | — | US | disclosed |
| EP-4059512-A1 | AQUEOUS PHARMACEUTICAL COMPOSITION CONTAINING FUSION PROTEIN OF SERUM ALBUMIN AND GROWTH HORMONE | JCR Pharmaceuticals Co., Ltd. (JP) | 2022-09-21 | — | — | EP | disclosed |
| EP-4047006-A1 | METHOD FOR PRODUCING FUSION PROTEIN OF SERUM ALBUMIN AND GROWTH HORMONE | JCR Pharmaceuticals Co., Ltd. (JP) | 2022-08-24 | — | — | EP | disclosed |
| CN-114728043-A | Aqueous pharmaceutical composition containing fusion protein of serum albumin and growth hormone | JCR制药股份有限公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-114591445-A | Novel human serum albumin mutant | JCR制药股份有限公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-114555646-A | Method for producing fusion protein of serum albumin and growth hormone | JCR制药股份有限公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-107949638-B | Novel human serum albumin mutants | JCR制药股份有限公司 | 2022-05-13 | — | — | CN | disclosed |
| EP-3845644-A1 | NOVEL HUMAN SERUM ALBUMIN MUTANT | JCR Pharmaceuticals Co., Ltd. (JP) | 2021-07-07 | — | — | EP | disclosed |
| US-11046751-B2 | Human serum albumin mutant | JCR PHARMACEUTICALS CO., LTD. (JP) | 2021-06-29 | — | — | US | disclosed |
| EP-3348635-B1 | NOVEL HUMAN SERUM ALBUMIN MUTANT | JAPAN CHEM RES (JP) | 2021-02-17 | — | — | EP | disclosed |
| US-20200247872-A1 | NOVEL HUMAN SERUM ALBUMIN MUTANT | JAPAN CHEM RES (JP) | 2020-08-06 | — | — | US | disclosed |
| US-10654912-B2 | Human serum albumin mutant | JCR PHARMACEUTICALS CO., LTD. (JP) | 2020-05-19 | — | — | US | disclosed |
| US-20180244754-A1 | NOVEL HUMAN SERUM ALBUMIN MUTANT | JCR PHARMACEUTICALS CO., LTD. (JP) | 2018-08-30 | — | — | US | disclosed |
| EP-3348635-A1 | NOVEL HUMAN SERUM ALBUMIN MUTANT | JCR Pharmaceuticals CO., LTD. (JP) | 2018-07-18 | — | — | EP | disclosed |